Kawasumi Laboratories Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017 and Full Year Ending March 31, 2018; Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018
For the six months ending September 30, 2017, the company expects net sales of ¥12,300 million, operating income of ¥100 million, ordinary income of ¥150 million and profit attributable to owners of the parent of ¥150 million or ¥6.88 per share.
For the full year ending March 31, 2018, the company expects net sales of ¥25,000 million, operating income of ¥600 million, ordinary income of ¥650 million and profit attributable to owners of the parent of ¥600 million or ¥27.50 per share.
For the fiscal year ending March 31, 2018, the company expects to pay second quarter-end dividend of JPY 7.50 per share against JPY 7.50 per share paid a year ago.
For the fiscal year ending March 31, 2018, the company expects to pay year-end dividend of JPY 7.50 per share against JPY 10.00 per share paid a year ago.